ATH 33.3% 0.4¢ alterity therapeutics limited

h c wainwright analyst, page-28

  1. 181 Posts.
    firstly, early 2000's it was approved for listing on nasdaq, but was listed here
    so I guess you are wrong

    Secondly, of course my expectations were not that it was going to take 18 years, most trials take 10 - 15 years, but they pulled out of phase 3 because they knew it was a failure and hence my disappointment and loss of faith in the company

    Colin Masters was involved then, not sure if he still is, a professor of Neurology at RMH
    He had faith and was well respected, however guess he was wrong
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.